Group One Trading
LTRN icon

Group One Trading’s Lantern Pharma LTRN Stock Holding History

Group One Trading’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96 Hold
23
– – ﹤0.01% 7409
2026
Q1 		$32 Sell
23
-4,049
-99% -$11.3K ﹤0.01% 7456
2025
Q4 		$12.3K Sell
4,072
-1,000
-20% -$3.72K ﹤0.01% 6685
2025
Q3 		$22.1K Buy
5,072
+2,100
+71% +$8.77K ﹤0.01% 6625
2025
Q2 		$9.39K Buy
+2,972
New +$10K ﹤0.01% 6758

Other funds holding LTRN

EAM
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Group One Trading's LTRN Position: Q2 2026 in Review

Group One Trading held its Lantern Pharma (LTRN) position steady in Q2 2026 at 23 shares worth $96. The position accounts for ﹤0.01% of the portfolio, ranked #7409.

Group One Trading first reported a position in LTRN in Q2 2025 and has held it in 5 quarters since. The position peaked at $22.1K in Q3 2025. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Group One Trading held 23 shares of Lantern Pharma worth $96 as of Q2 2026.
  • Group One Trading left its Lantern Pharma share count unchanged in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7409 holding.
  • Group One Trading first reported a position in Lantern Pharma in Q2 2025 and has held it in 5 quarters since.
  • Group One Trading's Lantern Pharma position peaked at $22.1K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.